# A Clinical Trial of MK-4082 in Healthy Participants (MK-4082-005)

> **NCT07697625** · PHASE1 · RECRUITING · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 28 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** MK-4082
- **DRUG:** Diltiazem
- **DRUG:** Rescue medication

## Key facts

- **NCT ID:** NCT07697625
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-07-20
- **Primary completion:** 2026-09-28
- **Final completion:** 2026-09-28
- **Target enrollment:** 28 (ESTIMATED)
- **Last updated:** 2026-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07697625

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07697625, "A Clinical Trial of MK-4082 in Healthy Participants (MK-4082-005)". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07697625. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*